BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 11, 2008
View Archived Issues
ArQule Makes Two Deals with Daiichi in Cancer
ArQule would receive $75 million in up-front cash under two deals with Japan's Daiichi Sankyo Co. Ltd. - one to develop an anticancer compound and the other to discover a new generation of kinase inhibitors for cancer. (BioWorld Today)
Read More
LDL Hypothesis Alive and Well; Other Biomarkers also Valuable
Read More
Improved T-Cell Receptor Takes on all Comers of HIV Epitope
Read More
Moving from Licensing Talks to M&A can be a Tricky Step
Read More
Regulatory Hitch to Delay Solzira Filing, Milestone to XenoPort
Read More
Other News To Note
Read More
Financings Roundup
Read More
Clinic Roundup
Read More